A Georgetown University study published in the journal JAMA Pediatrics says that there is a great deal of evidence that suggests that probiotics should be used to protect prematurely born infants from a dangerous and often deadly disease. Dr. Dan Merenstein of Georgetown University was the study’s senior author. The nearly half-million babies born prematurely every year in the U.S. are at risk of developing necrotizing enterocolitis (NEC), which affects the gastrointestinal tract by infecting it and destroying the bowel. According to the Georgetown website, the Georgetown University researchers believe that probiotics, a useful bacteria type, can help protect the intestinal tract and should be used with all premature babies with NEC.
Tags: 2014, 2013, Georgetown University, Washington DC, Northeast, probiotic research, D.C., Geotwn, BioResearch Product Faire Event, BioResearch University
Science researchers at Georgetown University recently published a study in the Journal of Infectious Diseases that shows that the human papillomavirus (HPV) vaccine a Georgetown University doctor helped to invent has lead to the number of infections among teenage girls across the United States being cut in half. According to a Georgetown University news article, the vaccine was created to treat and get rid of two forms of the HPV virus, which results in most cervical cancer cases nationwide, along with head and neck cancer, anal cancer and penile cancer.
Tags: 2014, 2013, Georgetown University, Washington DC, Northeast, D.C., Geotwn, BioResearch Product Faire Event
Scientists at Georgetown University conducted a study published in Human Molecular Genetics that gives insight into a groundbreaking new strategy for treating neurodegenerative diseases featuring an unusual buildup of proteins, such as Alzheimer’s disease, Parkinson’s, frontotemporal dementia, amyotrophic lateral sclerosis, Huntington disease and Lew body dementia, to name a few. According to a Georgetown University news article, the researchers found that when the drug nilotinib is used to treat chronic myelogenous leukemia, it causes cancer cells to go into autophagy, a biological process that causes the death of cancerous tumor cells.
Tags: 2014, 2013, Georgetown University, Washington DC, Northeast, D.C., Geotwn, BioResearch Product Faire Event
At Georgetown University's Lombardi Comprehensive Cancer Center, researchers have announced the results of an important study showing that high levels of estrogen in the mother during pregnancy can increase a daughter's susceptibility to breast cancer later on. Specifically, the BRCA1 gene is disabled in an estrogen-rich environment, preventing it from carrying out its DNA repair tasks and leaving an opening for cancerous cells to grow. The research was presented at the 2013 American Association for Cancer Research (AACR) meeting by Dr. Leena Hilakivi-Clarke (right). The Hilakivi-Clarke Lab is on the same floor of the Research Building as that of Dr. Robert Clarke, who collaborated on the study; the Clarkes both carry out hormone-related cancer research, and Robert Clarke is the Dean for Research at the Georgetown University Medical Center (GUMC).
Tags: 2014, 2013, Georgetown University, Washington DC, Northeast, gene patenting, cancer research, D.C., Geotwn, BioResearch Product Faire Event, Genetics, Georgetown University Medical Center
Tags: Georgetown University, Washington DC, Northeast, Multiple Sclerosis, new science wet labs, 2012, Neuroscience, Geotwn, BioResearch Product Faire Event, Biomedical Research Funding, charitable giving
Recently, Georgetown University researchers received a $3 million NIH bioresearch grant to open a new collaborative HIV/AIDS research center called the Developmental Center for AIDS Research (D-CFAR).
Tags: Georgetown University, Washington DC, Northeast, AIDS Research, BioResearch Product Faire Event, Funding, NIH, Georgetown
Traditionally, the only kind of conference with the steam to get a lot of people really worked up and to make headlines has been the sports variety, as in "Buffalo embarrasses Washington for critical conference win" or "Big East releases 2012 conference schedule." But a scientific conference with 1000 participants and hundreds of simulcasts by teaching hospitals, medical schools, research institutions, university life science departments, state and federal government agencies, health-oriented corporations and nonprofits across the nation? Welcome to TEDMED 2012, coming to Washington DC (and a big screen near you) this April 10-13, and generating a lot of buzz in its advance wake.
Tags: Washington DC, Northeast, Medical Research, Event, current science event, scientific conference, scientific conferences